High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics.

PubWeight™: 3.92‹?› | Rank: Top 1%

🔗 View Article (PMID 21218139)

Published in J Am Stat Assoc on December 01, 2008

Authors

Carlos M Carvalho1, Jeffrey Chang, Joseph E Lucas, Joseph R Nevins, Quanli Wang, Mike West

Author Affiliations

1: Assistant Professor of Econometrics and Statistics, The University of Chicago, Graduate School of Business, Chicago, IL 60637, carlos.carvalho@chicagogsb.edu.

Articles citing this

Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe (2009) 4.55

A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A (2010) 3.30

A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell (2009) 2.22

Large Covariance Estimation by Thresholding Principal Orthogonal Complements. J R Stat Soc Series B Stat Methodol (2013) 2.12

Analysis of population structure: a unifying framework and novel methods based on sparse factor analysis. PLoS Genet (2010) 2.06

Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. J Am Coll Cardiol (2013) 1.61

The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet (2008) 1.60

Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. PLoS One (2011) 1.57

Default Prior Distributions and Efficient Posterior Computation in Bayesian Factor Analysis. J Comput Graph Stat (2009) 1.45

A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One (2013) 1.37

Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet (2010) 1.34

CoGAPS: an R/C++ package to identify patterns and biological process activity in transcriptomic data. Bioinformatics (2010) 1.15

Testing for associations between loci and environmental gradients using latent factor mixed models. Mol Biol Evol (2013) 1.13

Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res (2012) 1.09

Predicting Viral Infection From High-Dimensional Biomarker Trajectories. J Am Stat Assoc (2011) 1.07

Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLoS One (2010) 1.07

A bayesian analysis strategy for cross-study translation of gene expression biomarkers. Stat Appl Genet Mol Biol (2009) 1.04

mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J Clin Invest (2013) 1.03

Matrix factorization for recovery of biological processes from microarray data. Methods Enzymol (2009) 1.02

Bayesian Gaussian Copula Factor Models for Mixed Data. J Am Stat Assoc (2013) 1.02

Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One (2013) 0.99

Bayesian inference of the number of factors in gene-expression analysis: application to human virus challenge studies. BMC Bioinformatics (2010) 0.98

CODEX: a normalization and copy number variation detection method for whole exome sequencing. Nucleic Acids Res (2015) 0.97

A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer. Breast Cancer Res (2014) 0.97

Cross-study projections of genomic biomarkers: an evaluation in cancer genomics. PLoS One (2009) 0.96

Knowledge-based data analysis comes of age. Brief Bioinform (2009) 0.95

Genome scans for detecting footprints of local adaptation using a Bayesian factor model. Mol Biol Evol (2014) 0.94

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors. Oncogene (2013) 0.92

Multivariate multi-way analysis of multi-source data. Bioinformatics (2010) 0.92

Dissecting high-dimensional phenotypes with bayesian sparse factor analysis of genetic covariance matrices. Genetics (2013) 0.92

An exploratory data analysis method to reveal modular latent structures in high-throughput data. BMC Bioinformatics (2010) 0.91

Simplex Factor Models for Multivariate Unordered Categorical Data. J Am Stat Assoc (2012) 0.90

Latent factor analysis to discover pathway-associated putative segmental aneuploidies in human cancers. PLoS Comput Biol (2010) 0.88

TESTING SIGNIFICANCE OF FEATURES BY LASSOED PRINCIPAL COMPONENTS. Ann Appl Stat (2008) 0.87

Posterior Contraction Rates of the Phylogenetic Indian Buffet Processes. Bayesian Anal (2015) 0.86

The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Mol Cell Biol (2014) 0.86

Covariance adjustment for batch effect in gene expression data. Stat Med (2014) 0.85

Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene (2011) 0.83

Matrix Factorization for Transcriptional Regulatory Network Inference. IEEE Symp Comput Intell Bioinforma Comput Biol Proc (2012) 0.82

Increased metastasis with loss of E2F2 in Myc-driven tumors. Oncotarget (2015) 0.82

Decomposition of RNA methylome reveals co-methylation patterns induced by latent enzymatic regulators of the epitranscriptome. Mol Biosyst (2014) 0.82

Deep learning with hierarchical convolutional factor analysis. IEEE Trans Pattern Anal Mach Intell (2013) 0.81

Metaprotein expression modeling for label-free quantitative proteomics. BMC Bioinformatics (2012) 0.81

Mathematical and statistical modeling in cancer systems biology. Front Physiol (2012) 0.81

SEPARABLE FACTOR ANALYSIS WITH APPLICATIONS TO MORTALITY DATA. Ann Appl Stat (2014) 0.81

Unsupervised Bayesian linear unmixing of gene expression microarrays. BMC Bioinformatics (2013) 0.79

AN INTEGRATIVE ANALYSIS OF CANCER GENE EXPRESSION STUDIES USING BAYESIAN LATENT FACTOR MODELING. Ann Appl Stat (2009) 0.79

Ancestral informative marker selection and population structure visualization using sparse Laplacian eigenfunctions. PLoS One (2010) 0.79

Semiparametric Bayesian local functional models for diffusion tensor tract statistics. Neuroimage (2012) 0.79

Fast and robust group-wise eQTL mapping using sparse graphical models. BMC Bioinformatics (2015) 0.79

Bayesian Learning in Sparse Graphical Factor Models via Variational Mean-Field Annealing. J Mach Learn Res (2010) 0.78

A Nonparametric Bayesian Model for Local Clustering with Application to Proteomics. J Am Stat Assoc (2013) 0.78

Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project. BMC Psychiatry (2016) 0.77

Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res (2015) 0.77

Bayesian non-negative factor analysis for reconstructing transcription factor mediated regulatory networks. Proteome Sci (2011) 0.77

High-Dimensional Longitudinal Genomic Data: An analysis used for monitoring viral infections. IEEE Signal Process Mag (2012) 0.76

Network-based modular latent structure analysis. BMC Bioinformatics (2014) 0.76

Generalized Dynamic Factor Models for Mixed-Measurement Time Series. J Comput Graph Stat (2014) 0.75

Host-based Peripheral Blood Gene Expression Analysis for the Diagnosis of Infectious Diseases. J Clin Microbiol (2016) 0.75

Bayesian Exploratory Factor Analysis. J Econom (2014) 0.75

Dynamic transcriptional signatures and network responses for clinical symptoms in influenza-infected human subjects using systems biology approaches. J Pharmacokinet Pharmacodyn (2014) 0.75

A Bayesian Nonparametric Approach for the Analysis of Multiple Categorical Item Responses. J Stat Plan Inference (2014) 0.75

Sparse principal component analysis in cancer research. Transl Cancer Res (2014) 0.75

CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network. Oncotarget (2016) 0.75

Computational dynamic approaches for temporal omics data with applications to systems medicine. BioData Min (2017) 0.75

Perturbation Detection Through Modeling of Gene Expression on a Latent Biological Pathway Network: A Bayesian hierarchical approach. J Am Stat Assoc (2016) 0.75

Context Specific and Differential Gene Co-expression Networks via Bayesian Biclustering. PLoS Comput Biol (2016) 0.75

A Dirichlet process mixture model for clustering longitudinal gene expression data. Stat Med (2017) 0.75

A Bayesian semiparametric factor analysis model for subtype identification. Stat Appl Genet Mol Biol (2017) 0.75

Articles cited by this

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A (2005) 13.54

Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30

The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02

Gene expression predictors of breast cancer outcomes. Lancet (2003) 6.99

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A (2003) 6.37

Minireview: Cyclin D1: normal and abnormal functions. Endocrinology (2004) 5.22

Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ (1998) 4.38

Gene selection: a Bayesian variable selection approach. Bioinformatics (2003) 3.14

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A (2004) 2.74

Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res (2005) 2.63

Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci U S A (1999) 2.19

Embracing the complexity of genomic data for personalized medicine. Genome Res (2006) 1.75

Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res (2006) 1.72

Bayesian hierarchical model for identifying changes in gene expression from microarray experiments. J Comput Biol (2002) 1.70

P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci U S A (1999) 1.68

Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet (2003) 1.51

Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res (2005) 1.37

Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biol (2002) 1.27

Gene expression profiling for prediction of clinical characteristics of breast cancer. Recent Prog Horm Res (2003) 1.04

Articles by these authors

Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56

Retracted Genomic signatures to guide the use of chemotherapeutics. Nat Med (2006) 7.45

Gene expression predictors of breast cancer outcomes. Lancet (2003) 6.99

Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med (2006) 6.69

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61

Retracted An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol (2007) 5.77

Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet (2013) 5.58

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol (2008) 4.45

Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet (2003) 3.78

Retracted Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol (2007) 3.67

A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A (2010) 3.30

Retracted Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA (2008) 3.26

GATHER: a systems approach to interpreting genomic signatures. Bioinformatics (2006) 3.22

An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell (2008) 3.07

Statistical mixture modeling for cell subtype identification in flow cytometry. Cytometry A (2008) 3.06

A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol (2008) 2.91

E2Fs link the control of G1/S and G2/M transcription. EMBO J (2004) 2.81

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80

Retracted Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol (2007) 2.80

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A (2004) 2.74

Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res (2005) 2.63

Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J (2002) 2.49

Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med (2007) 2.38

Understanding GPU Programming for Statistical Computation: Studies in Massively Parallel Massive Mixtures. J Comput Graph Stat (2010) 2.38

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res (2005) 2.37

Linking oncogenic pathways with therapeutic opportunities. Nat Rev Cancer (2006) 2.32

Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 2.23

A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell (2009) 2.22

Signaling networks that link cell proliferation and cell fate. J Biol Chem (2002) 1.91

Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc Natl Acad Sci U S A (2003) 1.89

Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol Cell Biol (2003) 1.76

Embracing the complexity of genomic data for personalized medicine. Genome Res (2006) 1.75

Image segmentation and dynamic lineage analysis in single-cell fluorescence microscopy. Cytometry A (2010) 1.75

Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res (2006) 1.72

Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem (2001) 1.70

Retracted A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A (2008) 1.69

Gene expression patterns that characterize advanced stage serous ovarian cancers. J Soc Gynecol Investig (2004) 1.68

The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet (2008) 1.60

High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients. Hepatology (2011) 1.59

Spatial Mixture Modelling for Unobserved Point Processes: Examples in Immunofluorescence Histology. Bayesian Anal (2009) 1.58

Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol (2006) 1.57

Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet (2003) 1.51

Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci U S A (2002) 1.51

The regulated association of Cdt1 with minichromosome maintenance proteins and Cdc6 in mammalian cells. J Biol Chem (2003) 1.46

Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. Breast Cancer Res Treat (2009) 1.46

Retracted An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS One (2008) 1.45

Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One (2008) 1.44

Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS One (2008) 1.43

A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev (2004) 1.42

A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One (2013) 1.37

Balancing the decision of cell proliferation and cell fate. Cell Cycle (2009) 1.36

Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J Biol Chem (2002) 1.36

Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples. PLoS Comput Biol (2013) 1.35

Combinatorial gene control involving E2F and E Box family members. EMBO J (2004) 1.35

Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet (2010) 1.34

Distinctions in the specificity of E2F function revealed by gene expression signatures. Proc Natl Acad Sci U S A (2005) 1.34

Origin of bistability underlying mammalian cell cycle entry. Mol Syst Biol (2011) 1.32

Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol (2004) 1.29

Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biol (2002) 1.27

Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proc Natl Acad Sci U S A (2009) 1.26

Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Res (2011) 1.26

Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res (2009) 1.26

Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res (2003) 1.26

Network calisthenics: control of E2F dynamics in cell cycle entry. Cell Cycle (2011) 1.25

Using a stem cell-based signature to guide therapeutic selection in cancer. Cancer Res (2010) 1.24

Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol (2010) 1.20

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer. Breast Cancer Res (2009) 1.19

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma. Cancer Res (2008) 1.19

Bayesian analysis of matrix normal graphical models. Biometrika (2009) 1.18

Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev (2006) 1.17

Effects of maternal multimicronutrient supplementation on the mental development of infants in rural western China: follow-up evaluation of a double-blind, randomized, controlled trial. Pediatrics (2009) 1.16

An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics (2008) 1.14

Genomic strategies for personalized cancer therapy. Hum Mol Genet (2007) 1.14

Retracted Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood (2005) 1.12

Utilization of genomic signatures to identify phenotype-specific drugs. PLoS One (2009) 1.12

Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A (2005) 1.09